EGFR and familial pancreatic carcinoma: In a different study, tetrahydroxycurcumin decreased cell survival and promoted apoptosis in lung and pancreatic cancer cell lines by downregulating EGFR and cyclooxygenase‐2 (COX‐2) (Liu et al. 2024).